| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 05/10/2002 | WO2002036562A2 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/10/2002 | WO2002028868A8 Thiazine derivatives |
| 05/10/2002 | WO2001032664A3 Novel thiophenes and method for polymerization of said thiophenes |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055511 Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors |
| 05/09/2002 | US20020055465 Nocathiacin antibiotics prepared by biotransformation or chemical methods |
| 05/08/2002 | EP1203769A1 Hypolipidemic 1,4-benzothiazepine derivative |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/07/2002 | US6384212 Directly acylating 7-amino cephalosporanic acid derivative with crystalline 2-aminothiazole compound; ceftazidime; cefixime; (2-carboxyprop-2-oxyimino)acetamido)-3-(1 -pyridiniummethyl)-ceph-3-em-4-carboxylate dihydrochloride |
| 05/07/2002 | US6384065 Spiro compounds or salts thereof and preventives/remedies for autoimmune diseases and AP-1 inhibitors containing the same |
| 05/07/2002 | US6384050 Tricyclic amine derivatives |
| 05/07/2002 | CA2216535C Protein kinase c inhibitors |
| 05/07/2002 | CA2052263C Herbicides |
| 05/02/2002 | WO2002002562A3 Heteropolycyclic inhibitors |
| 05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/02/2002 | EP1201670A2 Process for preparing 2-oxaisocephem derivatives |
| 05/02/2002 | EP1201669A2 Process for preparing halogenated cephem derivatives |
| 05/02/2002 | EP1201654A2 Process for preparing allenyl beta-lactam derivatives |
| 05/02/2002 | EP1200427A2 Small molecule modulators of g protein-coupled receptor six (gpr6) |
| 05/02/2002 | EP1200072A2 Method of treating psychotic disorders |
| 05/02/2002 | EP0888359B1 Pyrimidin-4-one derivatives as pesticide |
| 04/30/2002 | USRE37686 Biosynthesis of polypeptides |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380228 E.g., n-(2-phenylsulfonyl-1-ethyl)-3-(4-cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380134 N-pyridyl herbicide compounds |
| 04/30/2002 | US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
| 04/25/2002 | US20020049242 Condensed 4,5,6,7-tetrahydrobenzo[C]thiopenes as enhancer for cell differentiation induction factor action |
| 04/25/2002 | US20020049223 Quinoline and naphthyridine carboxylic acid antibacterials |
| 04/25/2002 | US20020049215 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 04/25/2002 | US20020049203 CRF receptor antagonists and methods relating thereto |
| 04/23/2002 | US6376487 Oxadiazine derivatives |
| 04/18/2002 | WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis |
| 04/18/2002 | WO2002030890A1 Nitrogenous five-membered ring compounds |
| 04/18/2002 | WO2002030358A2 Modulation of ccr4 function |
| 04/18/2002 | WO2002030357A2 Compounds and methods for modulating ccr4 function |
| 04/18/2002 | US20020045759 E.g., N-(2-Phenylsulfonyl-1-ethyl)-3-(4-Cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta |
| 04/18/2002 | US20020045635 Novel mGluR antagonists and a method for their synthesis |
| 04/18/2002 | CA2425259A1 Modulation of ccr4 function |
| 04/17/2002 | EP1196167A1 Method of reducing neuronal injury or apoptosis |
| 04/17/2002 | EP1015434B1 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/16/2002 | US6372742 Telomerase enzyme inhibitors and anticancer agents |
| 04/16/2002 | US6372682 Contacting one or more olefin monomers with a group 8-10 transition metal complex catalyst and optionally a bronsted or lewis acid |
| 04/11/2002 | WO2002028868A1 Thiazine derivatives |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028860A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/10/2002 | EP1194430A1 Novel process |
| 04/10/2002 | EP1194421A1 Selective npy (y5) antagonists |
| 04/10/2002 | EP0813535B1 Hexacyclic camptothecin analogues, and process for preparing them |
| 04/10/2002 | EP0712402B1 Hydroisoquinoline derivatives |
| 04/10/2002 | CN1344266A Novel compounds |
| 04/09/2002 | US6369227 Thrombin or factor Xa inhibitors |
| 04/09/2002 | US6369222 mGluR antagonists and a method for their synthesis |
| 04/09/2002 | US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369002 Hetero is pyrimidine or pyridazine; 1-(3-fluoro-5-chloro pyridin-2-yl)-3-methyl-4-trifluoromethylpyrimidin-2,6-dione |
| 04/09/2002 | CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use |
| 04/09/2002 | CA2093219C Amides of antibiotic ge 2270 factors |
| 04/04/2002 | WO2002026747A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidine derivatives with 5-ht receptor affinity |
| 04/04/2002 | WO2002014295A8 Thiazine derivatives having antibacterial and antiviral action |
| 04/04/2002 | US20020040017 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 04/03/2002 | EP1193257A2 Compounds for ceramide-mediated signal transduction |
| 04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
| 04/03/2002 | EP1192137A1 COMPOUNDS FOR THE MODULATION OF PPAR$g(g) ACTIVITY |
| 04/02/2002 | US6365751 Antibiotic oxazolidinone derivatives |
| 04/02/2002 | CA2053340C Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
| 03/28/2002 | WO2002024711A1 Novel thiazole bicyclic compounds |
| 03/28/2002 | WO2002024710A1 Tricyclic mercaptomethyl-substituted 2,3-dihydro-quinazolin-5-ones and 2,3-dihydro-benzo-[1,2,4]-thiadiazin-5,5-dioxides as matrix metalloproteinase (mmp) inhibitors |
| 03/28/2002 | WO2002024709A2 Bicycloderivatives as herbicides |
| 03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | US20020037894 5,5-dioxo-2,3,3a,4-tetrahydro-1 H-pyrrolo(2,1-c)(1,2,4)-benzothiadiazin-7-ol, for example; nervous system disorders; alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) modulators |
| 03/28/2002 | CA2422923A1 Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity |
| 03/27/2002 | EP1191020A2 Material for organic electroluminescence device and use thereof |
| 03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189890A1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 03/27/2002 | CN1341599A Novel benzodiazine compound, its preparation method and medicine composition containing them |
| 03/26/2002 | US6362191 Aminometyl oxooxazolidinyl benzene derivatives |
| 03/26/2002 | US6362177 Cyclic amine derivatives and their use as drugs |
| 03/26/2002 | US6361815 Isolation of purified product comprising 85% by weight of 3,4',5-trihydroxy-trans-stilbene from plant material containing trihydroxystilbenes and glycosylated derivatives thereof |
| 03/21/2002 | WO2002022614A1 Quinolizine derivatives |
| 03/21/2002 | WO2002022611A2 Caspase inhibitors and uses thereof |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors |
| 03/21/2002 | WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors |